Investors & Media

SEC Filing Details

Investor Relations Menu
Investor Home
News & Events
Press Releases Events & Presentations
Stock Information
Stock Quote & Chart Historic Price Lookup Investment Calculator Analyst Coverage
Financials & Filings
SEC Filings
Corporate Governance
Documents & Charters Management Team Board of Directors Scientific Advisory Board Committee Composition
Investor Resources
Investor FAQs Investor Contact Email Alerts
Contact

Elizabeth Pingpank Hickin
Vice President, Investor Relations
ehickin@zentalis.com

Document Details

Form
S-1MEF
Filing Date
Apr 2, 2020
Document Date
Apr 2, 2020
Form Description
Registration of up to an additional 20% of securities for any offering registered on an S-1
Filing Group
Registration Statements
Company
Zentalis Pharmaceuticals
Issuer
ZENTALIS PHARMACEUTICALS, INC.

Filing Formats

View HTML
Download PDF
Download DOC